Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esmolol or lidocaine infusion for recovery after thyroid surgery
ChiCTR1900025923Phase 4Recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and esmolol in thyroid disease (3 arms), sponsored by Huai'an Second Hospital. Primary endpoint: QoR-40 score. Started Sep 2019; status: recruiting.
02
Drugs
lidocaineesmolol
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ChiCTR1900025923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025923.